These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12729446)

  • 1. Summaries for patients. Duration of antibiotic treatment for early Lyme disease.
    Ann Intern Med; 2003 May; 138(9):I27. PubMed ID: 12729446
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
    Wormser GP; Ramanathan R; Nowakowski J; McKenna D; Holmgren D; Visintainer P; Dornbush R; Singh B; Nadelman RB
    Ann Intern Med; 2003 May; 138(9):697-704. PubMed ID: 12729423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of antibiotic therapy for Lyme disease.
    Steere AC
    Ann Intern Med; 2003 May; 138(9):761-2. PubMed ID: 12729432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythema migrans. Duration of antibiotic therapy?].
    Quadranti P; Hirsch HH
    Praxis (Bern 1994); 2005 Aug; 94(32):1223-4. PubMed ID: 16128211
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial.
    Stupica D; Velušcek M; Blagus R; Bogovic P; Rojko T; Cerar T; Strle F
    J Antimicrob Chemother; 2018 May; 73(5):1352-1358. PubMed ID: 29385444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.
    Klempner MS; Hu LT; Evans J; Schmid CH; Johnson GM; Trevino RP; Norton D; Levy L; Wall D; McCall J; Kosinski M; Weinstein A
    N Engl J Med; 2001 Jul; 345(2):85-92. PubMed ID: 11450676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease.
    Berende A; Nieuwenhuis L; Ter Hofstede HJM; Vos FJ; Vogelaar ML; Tromp M; van Middendorp H; Donders ART; Evers AWM; Kullberg BJ; Adang EMM
    PLoS One; 2018; 13(4):e0195260. PubMed ID: 29608590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.
    Oksi J; Nikoskelainen J; Hiekkanen H; Lauhio A; Peltomaa M; Pitkäranta A; Nyman D; Granlund H; Carlsson SA; Seppälä I; Valtonen V; Viljanen M
    Eur J Clin Microbiol Infect Dis; 2007 Aug; 26(8):571-81. PubMed ID: 17587070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocol.
    Torbahn G; Hofmann H; Allert R; Freitag MH; Dersch R; Fingerle V; Sommer H; Motschall E; Meerpohl JJ; Schmucker C
    Syst Rev; 2016 May; 5():73. PubMed ID: 27142846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
    Ljøstad U; Skogvoll E; Eikeland R; Midgard R; Skarpaas T; Berg A; Mygland A
    Lancet Neurol; 2008 Aug; 7(8):690-5. PubMed ID: 18567539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis.
    Egberts F; Möller M; Proksch E; Schwarz T
    J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stage-oriented treatment of Lyme borreliosis].
    Fingerle V; Wilske B
    MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of treatment for Lyme borreliosis: time for a critical reappraisal.
    Wormser GP; Nowakowski J; Nadelman RB
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):613-5. PubMed ID: 12422611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up.
    Eliassen KE; Reiso H; Berild D; Lindbæk M
    Clin Microbiol Infect; 2018 Dec; 24(12):1290-1296. PubMed ID: 29505880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy after tick bite. Please give exact dosage and time].
    Spernau S
    MMW Fortschr Med; 2003 Oct; 145(43):22. PubMed ID: 14652935
    [No Abstract]   [Full Text] [Related]  

  • 16. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans.
    Nowakowski J; Nadelman RB; Forseter G; McKenna D; Wormser GP
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):223-7. PubMed ID: 7829706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.
    Ogrinc K; Logar M; Lotric-Furlan S; Cerar D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):696-701. PubMed ID: 17160610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective symptoms after treatment of early Lyme disease.
    Cerar D; Cerar T; Ruzić-Sabljić E; Wormser GP; Strle F
    Am J Med; 2010 Jan; 123(1):79-86. PubMed ID: 20102996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.
    Berende A; ter Hofstede HJ; Vos FJ; van Middendorp H; Vogelaar ML; Tromp M; van den Hoogen FH; Donders AR; Evers AW; Kullberg BJ
    N Engl J Med; 2016 Mar; 374(13):1209-20. PubMed ID: 27028911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose doxycycline for the prevention of Lyme disease.
    Pontrelli L; Dattwyler R; Nachman S
    N Engl J Med; 2001 Nov; 345(18):1348; author reply 1349-50. PubMed ID: 11794160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.